Amneal Pharmaceuticals (AMRX) Competitors

Amneal Pharmaceuticals (NASDAQ:AMRX) and Ascendis Pharma A/S (NASDAQ:ASND) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, community ranking, media sentiment, profitability, dividends, valuation, analyst recommendations and institutional ownership.

Does the MarketBeat Community favor AMRX or ASND?

Ascendis Pharma A/S received 429 more outperform votes than Amneal Pharmaceuticals when rated by MarketBeat users. However, 94.74% of users gave Amneal Pharmaceuticals an outperform vote while only 66.82% of users gave Ascendis Pharma A/S an outperform vote.

Company	Underperform	Outperform
Amneal Pharmaceuticals	Outperform Votes 18 94.74%	Underperform Votes 1 5.26%
Ascendis Pharma A/S	Outperform Votes 447 66.82%	Underperform Votes 222 33.18%

Is AMRX or ASND more profitable?

Amneal Pharmaceuticals has a net margin of -6.88% compared to Ascendis Pharma A/S's net margin of -104.54%. Ascendis Pharma A/S's return on equity of 0.00% beat Amneal Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Amneal Pharmaceuticals	-6.88%	-346.26%	4.85%
Ascendis Pharma A/S	-104.54%	N/A	-39.23%

Do analysts rate AMRX or ASND?

Amneal Pharmaceuticals currently has a consensus target price of $10.80, indicating a potential upside of 21.48%. Ascendis Pharma A/S has a consensus target price of $204.64, indicating a potential upside of 21.82%. Given Ascendis Pharma A/S's higher probable upside, analysts plainly believe Ascendis Pharma A/S is more favorable than Amneal Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Amneal Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00
Ascendis Pharma A/S	0 Sell rating(s)	1 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.93

Does the media prefer AMRX or ASND?

In the previous week, Amneal Pharmaceuticals and Amneal Pharmaceuticals both had 9 articles in the media. Amneal Pharmaceuticals' average media sentiment score of 1.19 beat Ascendis Pharma A/S's score of 0.58 indicating that Amneal Pharmaceuticals is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Amneal Pharmaceuticals	8 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Ascendis Pharma A/S	4 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do insiders & institutionals believe in AMRX or ASND?

31.8% of Amneal Pharmaceuticals shares are held by institutional investors. 26.6% of Amneal Pharmaceuticals shares are held by insiders. Comparatively, 40.0% of Ascendis Pharma A/S shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Which has more volatility and risk, AMRX or ASND?

Amneal Pharmaceuticals has a beta of 1.05, meaning that its share price is 5% more volatile than the S&P 500. Comparatively, Ascendis Pharma A/S has a beta of 0.62, meaning that its share price is 38% less volatile than the S&P 500.

Which has higher earnings and valuation, AMRX or ASND?

Amneal Pharmaceuticals has higher revenue and earnings than Ascendis Pharma A/S. Ascendis Pharma A/S is trading at a lower price-to-earnings ratio than Amneal Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Amneal Pharmaceuticals	$2.79B	0.99	-$83.99M	-$0.38	-23.39
Ascendis Pharma A/S	$363.64M	28.04	-$409.12M	-$7.10	-23.66

Summary

Amneal Pharmaceuticals beats Ascendis Pharma A/S on 11 of the 17 factors compared between the two stocks.